Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Biliary Tract Diseases

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    April 2019
  1. PAN P, Zhao SB, Wang S, Li Z, et al
    Biliary dilatation in a 67-year-old woman: seeing is believing.
    Gut. 2019 Apr 17. pii: gutjnl-2018-318200. doi: 10.1136/gutjnl-2018-318200.
    PubMed     Text format    


  2. SINGHI AD, Nikiforova MN, Chennat J, Papachristou GI, et al
    Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures.
    Gut. 2019 Apr 10. pii: gutjnl-2018-317817. doi: 10.1136/gutjnl-2018-317817.
    PubMed     Text format     Abstract available


    March 2019
  3. RUPP C, Hippchen T, Bruckner T, Kloters-Plachky P, et al
    Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis.
    Gut. 2019 Mar 25. pii: gutjnl-2018-316801. doi: 10.1136/gutjnl-2018-316801.
    PubMed     Text format     Abstract available


  4. KASPER P, Goeser T, Nierhoff D
    Oesophageal and scaly skin lesions associated with chronic cholestatic liver disease.
    Gut. 2019 Mar 16. pii: gutjnl-2019-318502. doi: 10.1136/gutjnl-2019-318502.
    PubMed     Text format    


  5. LIAO L, Schneider KM, Galvez EJC, Frissen M, et al
    Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
    Gut. 2019 Mar 14. pii: gutjnl-2018-316670. doi: 10.1136/gutjnl-2018-316670.
    PubMed     Text format     Abstract available


    February 2019
  6. KATO Y, Azuma K, Someda H, Shiokawa M, et al
    Case of IgG4-associated sclerosing cholangitis with normal serum IgG4 concentration, diagnosed by anti-laminin 511-E8 antibody: a novel autoantibody in patients with autoimmune pancreatitis.
    Gut. 2019 Feb 13. pii: gutjnl-2018-317934. doi: 10.1136/gutjnl-2018-317934.
    PubMed     Text format    


  7. MULLISH BH, McDonald JAK, Pechlivanis A, Allegretti JR, et al
    Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection.
    Gut. 2019 Feb 11. pii: gutjnl-2018-317842. doi: 10.1136/gutjnl-2018-317842.
    PubMed     Text format     Abstract available


  8. MERLEN G, Kahale N, Ursic-Bedoya J, Bidault-Jourdainne V, et al
    TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function.
    Gut. 2019 Feb 5. pii: gutjnl-2018-316975. doi: 10.1136/gutjnl-2018-316975.
    PubMed     Text format     Abstract available


    January 2019
  9. LI T, Guo H, Li H, Jiang Y, et al
    MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia.
    Gut. 2019 Jan 11. pii: gutjnl-2017-315318. doi: 10.1136/gutjnl-2017-315318.
    PubMed     Text format     Abstract available


    November 2018
  10. LIU Z, Alsaggaf R, McGlynn KA, Anderson LA, et al
    Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink.
    Gut. 2018 Nov 17. pii: gutjnl-2018-317504. doi: 10.1136/gutjnl-2018-317504.
    PubMed     Text format     Abstract available


    September 2018
  11. KREMER AE, Le Cleac'h A, Lemoinne S, Wolf K, et al
    Antipruritic effect of bezafibrate and serum autotaxin measures in patients with primary biliary cholangitis.
    Gut. 2018 Sep 18. pii: gutjnl-2018-317426. doi: 10.1136/gutjnl-2018-317426.
    PubMed     Text format    


    August 2018
  12. TAN LZ, Reilly CR, Steward-Harrison LC, Balouch F, et al
    Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis.
    Gut. 2018 Aug 21. pii: gutjnl-2018-316599. doi: 10.1136/gutjnl-2018-316599.
    PubMed     Text format    


    July 2018
  13. CHUANG SC, Lin CC, Peng CY, Huang WH, et al
    Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study.
    Gut. 2018 Jul 17. pii: gutjnl-2018-316899. doi: 10.1136/gutjnl-2018-316899.
    PubMed     Text format    


    June 2018
  14. LI M, Liu F, Zhang F, Zhou W, et al
    Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.
    Gut. 2018 Jun 28. pii: gutjnl-2018-316039. doi: 10.1136/gutjnl-2018-316039.
    PubMed     Text format     Abstract available


    April 2018
  15. JAHN D, Marzioni M, Geier A
    Manipulation of the gut-liver axis by interruption of bile acid recirculation: an option for the treatment of sclerosing cholangitis?
    Gut. 2018 Apr 20. pii: gutjnl-2018-316375. doi: 10.1136/gutjnl-2018-316375.
    PubMed     Text format    


  16. FUCHS CD, Paumgartner G, Mlitz V, Kunczer V, et al
    Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(-/-) mice by modulating composition, signalling and excretion of faecal bile acids.
    Gut. 2018 Apr 10. pii: gutjnl-2017-314553. doi: 10.1136/gutjnl-2017-314553.
    PubMed     Text format     Abstract available


  17. HUBERS LM, Vos H, Schuurman AR, Erken R, et al
    Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease.
    Gut. 2018;67:728-735.
    PubMed     Text format     Abstract available


    March 2018
  18. HIRSCHFIELD GM, Dyson JK, Alexander GJM, Chapman MH, et al
    The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.
    Gut. 2018 Mar 28. pii: gutjnl-2017-315259. doi: 10.1136/gutjnl-2017-315259.
    PubMed     Text format     Abstract available


    August 2017
  19. ALBERTS R, de Vries EMG, Goode EC, Jiang X, et al
    Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
    Gut. 2017 Aug 4. pii: gutjnl-2016-313598. doi: 10.1136/gutjnl-2016-313598.
    PubMed     Text format     Abstract available


  20. JIAO N, Baker SS, Chapa-Rodriguez A, Liu W, et al
    Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
    Gut. 2017 Aug 3. pii: gutjnl-2017-314307. doi: 10.1136/gutjnl-2017-314307.
    PubMed     Text format     Abstract available


    July 2017
  21. DE VRIES EM, Wang J, Williamson KD, Leeflang MM, et al
    A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.
    Gut. 2017 Jul 24. pii: gutjnl-2016-313681. doi: 10.1136/gutjnl-2016-313681.
    PubMed     Text format     Abstract available


  22. O'HARA SP, Karlsen TH, LaRusso NF
    Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
    Gut. 2017 Jul 21. pii: gutjnl-2017-314249. doi: 10.1136/gutjnl-2017-314249.
    PubMed     Text format    


    April 2017
  23. HUO X, Zhang X, Yu C, Cheng E, et al
    Aspirin prevents NF-kappaB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.
    Gut. 2017 Apr 25. pii: gutjnl-2016-313584. doi: 10.1136/gutjnl-2016-313584.
    PubMed     Text format     Abstract available


  24. TRIVEDI PJ, Tickle J, Vesterhus MN, Eddowes PJ, et al
    Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner.
    Gut. 2017 Apr 20. pii: gutjnl-2016-312354. doi: 10.1136/gutjnl-2016-312354.
    PubMed     Text format     Abstract available


    March 2017
  25. HANN A, Zizer E, Egger K, Allescher HD, et al
    Fatal outcome due to CO2 emboli during direct cholangioscopy.
    Gut. 2017 Mar 30. pii: gutjnl-2017-313988. doi: 10.1136/gutjnl-2017-313988.
    PubMed     Text format    


    February 2017
  26. TANG R, Wei Y, Li Y, Chen W, et al
    Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy.
    Gut. 2017 Feb 17. pii: gutjnl-2016-313332. doi: 10.1136/gutjnl-2016-313332.
    PubMed     Text format     Abstract available


  27. QURAISHI MN, Sergeant M, Kay G, Iqbal T, et al
    The gut-adherent microbiota of PSC-IBD is distinct to that of IBD.
    Gut. 2017;66:386-388.
    PubMed     Text format    


    January 2017
  28. WILLIAMS E, Beckingham I, El Sayed G, Gurusamy K, et al
    Updated guideline on the management of common bile duct stones (CBDS).
    Gut. 2017 Jan 25. pii: gutjnl-2016-312317. doi: 10.1136/gutjnl-2016-312317.
    PubMed     Text format     Abstract available


    December 2016
  29. FERNANDEZ-BARRENA MG, Perugorria MJ, Banales JM
    Novel lncRNA T-UCR as a potential downstream driver of the Wnt/beta-catenin pathway in hepatobiliary carcinogenesis.
    Gut. 2016 Dec 16. pii: gutjnl-2016-312899. doi: 10.1136/gutjnl-2016-312899.
    PubMed     Text format    


    September 2016
  30. SINGH A, Smith PJ, Cropley IM, Planche KL, et al
    Gallstone mimicry: a rare cause of abdominal pain.
    Gut. 2016 Sep 29. pii: gutjnl-2016-312706. doi: 10.1136/gutjnl-2016-312706.
    PubMed     Text format    


  31. IWASAWA K, Suda W, Tsunoda T, Oikawa-Kawamoto M, et al
    Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis.
    Gut. 2016 Sep 26. pii: gutjnl-2016-312533. doi: 10.1136/gutjnl-2016-312533.
    PubMed     Text format    


  32. CAROTENUTO P, Fassan M, Pandolfo R, Lampis A, et al
    Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers.
    Gut. 2016 Sep 12. pii: gutjnl-2016-312278. doi: 10.1136/gutjnl-2016-312278.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: